We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
13.50 | 0.83% | 1,649.50 | 1,649.00 | 1,650.00 | 1,656.00 | 1,635.00 | 1,642.00 | 1,448,526 | 12:14:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.78 | 67.93B |
TIDMGSK
RNS Number : 0220C
GlaxoSmithKline PLC
12 June 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ===================================================================== a) Name Ms E Walmsley === ======================== =========================================== b) Position/status Chief Executive Officer === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) GBP15.8480 7 (partnership shares) ----------------------- GBP15.8480 7 (matching shares) ----------------------- === ======================== =========================================== d) Aggregated information Aggregated volume Price 14 Ordinary Shares GBP15.8480 === ======================== =========================================== e) Date of the transaction 2019-06-11 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') ====================================================================== a) Name Mr R G Connor === ======================== ============================================ b) Position/status President, Global Vaccines === ======================== ============================================ c) Initial notification/ Initial notification amendment === ======================== ============================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================ b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== ============================================ c) Price(s) and Price(s) Volume(s) volume(s) GBP15.8480 8 (partnership shares) ----------------------- GBP15.8480 8 (matching shares) ----------------------- === ======================== ============================================ d) Aggregated information Aggregated volume Price 16 Ordinary Shares GBP15.8480 === ======================== ============================================ e) Date of the transaction 2019-06-11 === ======================== ============================================ f) Place of the London Stock Exchange (XLON) transaction === ======================== ============================================ 1. Details of PDMR/person closely associated with them ('PCA') ===================================================================== a) Name Mr N Hirons === ======================== =========================================== b) Position/status SVP, Global Ethics and Compliance === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) GBP15.8480 8 (partnership shares) ----------------------- GBP15.8480 8 (matching shares) ----------------------- === ======================== =========================================== d) Aggregated information Aggregated volume Price 16 Ordinary Shares GBP15.8480 === ======================== =========================================== e) Date of the transaction 2019-06-11 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') ====================================================================== a) Name Ms S Jackson === ======================== ============================================ b) Position/status SVP, Global Communications and CEO Office === ======================== ============================================ c) Initial notification/ Initial notification amendment === ======================== ============================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================ b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== ============================================ c) Price(s) and Price(s) Volume(s)
volume(s) GBP15.8480 8 (partnership shares) ----------------------- GBP15.8480 8 (matching shares) ----------------------- === ======================== ============================================ d) Aggregated information Aggregated volume Price 16 Ordinary Shares GBP15.8480 === ======================== ============================================ e) Date of the transaction 2019-06-11 === ======================== ============================================ f) Place of the London Stock Exchange (XLON) transaction === ======================== ============================================ 1. Details of PDMR/person closely associated with them ('PCA') ========================================================================= a) Name Mr D Jackson === ======================== =============================================== b) Position/status PCA of Ms S Jackson (SVP, Global Communications and CEO Office) === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =============================================== b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) GBP15.8480 8 (partnership shares) ----------------------- GBP15.8480 8 (matching shares) ----------------------- === ======================== =============================================== d) Aggregated information Aggregated volume Price 16 Ordinary Shares GBP15.8480 === ======================== =============================================== e) Date of the transaction 2019-06-11 === ======================== =============================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') ====================================================================== a) Name Mr D S Redfern === ======================== ============================================ b) Position/status Chief Strategy Officer === ======================== ============================================ c) Initial notification/ Initial notification amendment === ======================== ============================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================ b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== ============================================ c) Price(s) and Price(s) Volume(s) volume(s) GBP15.8480 7 (partnership shares) ----------------------- GBP15.8480 7 (matching shares) ----------------------- === ======================== ============================================ d) Aggregated information Aggregated volume Price 14 Ordinary Shares GBP15.8480 === ======================== ============================================ e) Date of the transaction 2019-06-11 === ======================== ============================================ f) Place of the London Stock Exchange (XLON) transaction === ======================== ============================================ 1. Details of PDMR/person closely associated with them ('PCA') ====================================================================== a) Name Mr R Simard === ======================== ============================================ b) Position/status President, Pharma Supply Chain === ======================== ============================================ c) Initial notification/ Initial notification amendment === ======================== ============================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================ b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== ============================================ c) Price(s) and Price(s) Volume(s) volume(s) GBP15.8480 8 (partnership shares) ----------------------- GBP15.8480 8 (matching shares) ----------------------- === ======================== ============================================ d) Aggregated information Aggregated volume Price 16 Ordinary Shares GBP15.8480 === ======================== ============================================ e) Date of the transaction 2019-06-11 === ======================== ============================================ f) Place of the London Stock Exchange (XLON) transaction === ======================== ============================================ 1. Details of PDMR/person closely associated with them ('PCA') ====================================================================== a) Name Mr P C Thomson === ======================== ============================================ b) Position/status President, Global Affairs === ======================== ============================================ c) Initial notification/ Initial notification amendment === ======================== ============================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================ b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================ b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== ============================================ c) Price(s) and Price(s) Volume(s) volume(s) GBP15.8480 8 (partnership shares) ----------------------- GBP15.8480 8 (matching shares) ----------------------- === ======================== ============================================ d) Aggregated information Aggregated volume Price 16 Ordinary Shares GBP15.8480 === ======================== ============================================ e) Date of the transaction 2019-06-11 === ======================== ============================================ f) Place of the London Stock Exchange (XLON) transaction === ======================== ============================================ 1. Details of PDMR/person closely associated with them ('PCA') ====================================================================== a) Name Mrs V A Whyte === ======================== ============================================ b) Position/status Company Secretary === ======================== ============================================ c) Initial notification/ Initial notification amendment === ======================== ============================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================ b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== ============================================ c) Price(s) and Price(s) Volume(s) volume(s) GBP15.8480 8 (partnership shares) ----------------------- GBP15.8480 8 (matching shares) ----------------------- === ======================== ============================================ d) Aggregated information Aggregated volume Price 16 Ordinary Shares GBP15.8480 === ======================== ============================================ e) Date of the transaction 2019-06-11 === ======================== ============================================ f) Place of the London Stock Exchange (XLON) transaction === ======================== ============================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHQLLFFKQFBBBB
(END) Dow Jones Newswires
June 12, 2019 12:10 ET (16:10 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions